Nothing Special   »   [go: up one dir, main page]

10 Control of Microbe in The BODY

Download as pdf or txt
Download as pdf or txt
You are on page 1of 51

CONTROL OF

MICROBE IN THE
BODY
Loading…
Clinical Considerations in Prescribing Antimicrobial Drugs

1. Readily available 4. Easily administered


2. Inexpensive 5. Nontoxic and non-allergenic
3. Chemically stable 6. Selectively toxic
Loading…
Loading…
Spectrum of Action
- is the no. of different kinds of pathogens a drug acts against
a. narrow-spectrum drugs
b. broad-spectrum drugs
Efficacy
a. Diffusion Susceptibility Test (Kirby-Bauer Method)

b. Minimum Inhibitory Concentration (MIC)

- is the smallest amount of drug that will inhibit growth and


reproduction of the pathogen

- determine via a broth dilution test (turbidity)

c. Minimum Bactericidal Concentration (MBC) Test


- the lowest concentration of drug for which no growth
occurs in the Subcultures
Safety and Side Effects
a. Toxicity
b. Allergies
c. Disruption of normal microbiota


Characteristics of Chemotherapeutic Agents

1. Highly toxic to a large number of pathogens.

2. No toxicity to the host.

3. Does not induce the development of antibiotic resistance in mutant


MQs.

“ 4. Will not induce hypersensitivity in the host.

5. Does not interfere with the host’s normal defense mechanism.


Factors Influencing Therapeutic Value

1. The susceptibility of the pathogen to the chemotherapeutic agent.

2. The drugs spectrum of activity.

3. Possible adverse reactions to the drug.


4. The drugs distribution within the body.

5. Metabolism of the drug in the body.

6. Duration of treatment.

7. Interactions with other drugs the patient maybe taking.


1. The Development of Resistance in Populations
a. new mutations of chromosomal genes
b. by acquiring resistance genes on extra-chromosomal pieces of
DNA called R-plasmids or R-factors via transformation,
transduction, or conjugation.


2. Mechanisms of Resistance

a. Resistant bacteria may produce an enzyme that destroys or deactivates the


drug. (e.g. penicillinase)

b. Resistant pathogens may slow or prevent the entry of the drug into the
cell. (e.g. altered porins)

“ Loading…
c. Resistant cells may alter the receptor for the drug so that it either
cannot attach to or binds less effectively to its target.
(sulfonamides, erythromycin)

d. Resistant cells may alter their metabolic chemistry or they may


abandon the susceptible and then metabolic chemistry stops
altogether.

e. Resistant cells may pump the drug out of the cell before the drug
can act.

Multiple Resistance and Cross Resistance

- multiple resistance is resistance to more than one drug at a time


- cross resistance is resistance to one drug, and confers resistance to similar drugs
Retarding Resistance

1. First, sufficiently high concentrations of the drug can be maintained in a patient’s


body for long, enough time to kill all susceptible cells and inhibit others long enough for


the body’s defenses to defeat them.

2. Then, use antimicrobial agent in combination so that pathogens resistant to one drug
will be killed by the second, and vice versa.

Synergism – one drug enhances the effect of the second drug; e.g. penicillin and
streptomycin
Antagonistic – interfering with each other

3. Lastly, is to limit the use of antimicrobial agent to necessary cases.



Thank you for
your kind
attention !

You might also like